tiprankstipranks
Advertisement
Advertisement

NBTX Stock Latest News

RatingsNanobiotix: Platform Expansion Potential and Risk-Adjusted NBTXR3 Valuation Support Buy Rating
6d ago
NBTX
Nanobiotix Unveils Preclinical Data Showing Nanoprimer Boosts LNP-DNA Cancer Immunotherapy
PremiumCompany Announcements
Nanobiotix Unveils Preclinical Data Showing Nanoprimer Boosts LNP-DNA Cancer Immunotherapy
8d ago
6K
NBTX
Nanobiotix price target raised to EUR 34 from EUR 32 at H.C. Wainwright
PremiumThe Fly
Nanobiotix price target raised to EUR 34 from EUR 32 at H.C. Wainwright
15d ago
NBTX
Nanobiotix Updates Share Capital and Voting Rights as of March 31, 2026
PremiumCompany Announcements
Nanobiotix Updates Share Capital and Voting Rights as of March 31, 2026
21d ago
6K
NBTX
Nanobiotix price target raised to $36 from $26 at Guggenheim
PremiumThe Fly
Nanobiotix price target raised to $36 from $26 at Guggenheim
26d ago
NBTX
Nanobiotix: Late-Stage NBTXR3 Pipeline and Partnerships Underpin Buy-Rated Risk-Reward Profile
PremiumRatingsNanobiotix: Late-Stage NBTXR3 Pipeline and Partnerships Underpin Buy-Rated Risk-Reward Profile
27d ago
NBTX
Nanobiotix price target raised to $37 from $26 at Leerink
Premium
The Fly
Nanobiotix price target raised to $37 from $26 at Leerink
27d ago
NBTX
Nanobiotix Extends Cash Runway to 2028 as JNJ-1900 Oncology Program Advances and 2025 Results Filed
Premium
Company Announcements
Nanobiotix Extends Cash Runway to 2028 as JNJ-1900 Oncology Program Advances and 2025 Results Filed
28d ago
6K
NBTX
Robust Phase 2 CONVERGE Data for JNJ-1900 Underpin Buy Rating and €32 Price Target on Nanobiotix
PremiumRatings
Robust Phase 2 CONVERGE Data for JNJ-1900 Underpin Buy Rating and €32 Price Target on Nanobiotix
29d ago
NBTX
Nanobiotix price target raised to EUR 32 from EUR 23 at H.C. Wainwright
PremiumThe Fly
Nanobiotix price target raised to EUR 32 from EUR 23 at H.C. Wainwright
29d ago
NBTX
Nanobiotix presents first data from CONVERGE study
PremiumThe Fly
Nanobiotix presents first data from CONVERGE study
29d ago
JNJ
NBTX
Nanobiotix Reports First Positive Phase 2 Data for NBTXR3 in Inoperable Stage 3 Lung Cancer
PremiumCompany Announcements
Nanobiotix Reports First Positive Phase 2 Data for NBTXR3 in Inoperable Stage 3 Lung Cancer
29d ago
6K
NBTX
Nanobiotix Sets March 31 Release for Fourth-Quarter and Full-Year 2025 Results
PremiumCompany AnnouncementsNanobiotix Sets March 31 Release for Fourth-Quarter and Full-Year 2025 Results
1M ago
6K
NBTX
Nanobiotix Denies Takeover Intentions Amid Media Speculation
Premium
Company Announcements
Nanobiotix Denies Takeover Intentions Amid Media Speculation
1M ago
6K
NBTX
Nanobiotix says ‘no such intention’ for company to acquire control
Premium
The Fly
Nanobiotix says ‘no such intention’ for company to acquire control
1M ago
NBTX
Nanobiotix Updates Share Capital and Voting Rights as of February 28, 2026
PremiumCompany Announcements
Nanobiotix Updates Share Capital and Voting Rights as of February 28, 2026
2M ago
6K
NBTX
Nanobiotix Ramps Up Investor Outreach With March 2026 U.S. Conference Lineup
PremiumCompany Announcements
Nanobiotix Ramps Up Investor Outreach With March 2026 U.S. Conference Lineup
2M ago
6K
NBTX
Nanobiotix initiated with a Buy at TD Cowen
PremiumThe Fly
Nanobiotix initiated with a Buy at TD Cowen
3M ago
NBTX
Nanobiotix: Differentiated Radiotherapy Enhancer, J&J Partnership, and Multi-Indication Pipeline Undervalue Long-Term Upside, Supporting Buy Rating
PremiumRatings
Nanobiotix: Differentiated Radiotherapy Enhancer, J&J Partnership, and Multi-Indication Pipeline Undervalue Long-Term Upside, Supporting Buy Rating
3M ago
NBTX
Undervalued Royalty Stream and De‑Risked Partnership Economics Underpin Nanobiotix Buy Rating
PremiumRatingsUndervalued Royalty Stream and De‑Risked Partnership Economics Underpin Nanobiotix Buy Rating
3M ago
NBTX
Nanobiotix Announces Share Capital and Voting Rights Update as of November 30, 2025
Premium
Company Announcements
Nanobiotix Announces Share Capital and Voting Rights Update as of November 30, 2025
4M ago
6K
NBTX
Nanobiotix Joins CAC Mid 60 and SBF 120 Indices
Premium
Company Announcements
Nanobiotix Joins CAC Mid 60 and SBF 120 Indices
4M ago
6K
NBTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >